HENDERSON MOLLY (CFO and CBO) sold 2.0% of their position (2.13K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $15.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/21/2023ACC: 0001209191-23-056288
Officer· CFO and CBO
Since Apr 2022
-2.13K
Net shares
Net seller
$15.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.13K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.13K
Price / share
$7.24
Trade value
$15.40K
% of position
2.0%
11/20/2023
105.19K→103.06K
Total
Net shares
−2.13K
Net value
-$15.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2023 | S · Sale | −2.13K | $7.24 | $15.40K | 2.0% | 105.19K | 103.06K |
| Total | −2.13K | -$15.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.13K
Total
1.13K indirect1.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.13K | Indirect |
| Total | 1.13K | 1.13K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported